Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member TIRAT HACARMEL, Israel, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Minovia Therapeutics (Minovia), a clinical-stage company focused on developing novel Mitochondrial Augmentation Technology (MAT) to fight...

Minovia Therapeutics to Present at Biotech Showcase on Tuesday, January 10, 2023 WOBURN, Mass. and HAIFA, Israel, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minovia Therapeutics, a clinical-stage global biotechnology company, today announced that the Company will be presenting at the...